FDA Inspection 1271026 — McKesson Pharmaceuticals Corporation

McKesson Pharmaceuticals Corporation — FEI 2910520

The FDA completed an inspection of McKesson Pharmaceuticals Corporation on May 12, 2025 in West Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 12, 2025
Fiscal Year
2025
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
West Sacramento, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.